For the Clinician Who Needs More Than a Label
When a pediatric practitioner recommends a supplement to a family, they are doing more than suggesting a product. They are extending their professional credibility. That is not a small thing. It is why so many clinicians—regardless of their openness to nutritional interventions—approach the supplement space with caution. The standards of evidence are inconsistent, the ingredient sourcing is often opaque, and the third-party testing, when it exists at all, is rarely comprehensive.
Agebox™ was designed with this clinical reality in mind. Its Practitioner Program, now active with more than 6,000 healthcare providers globally, is structured around a single premise: practitioners should never have to recommend something they cannot fully interrogate.
The Agebox Safety Framework
Agebox’s approach to product safety begins upstream, at the point of ingredient selection—where the Acesvia™ platform’s bioactive purification process systematically removes inactive and potentially interfering compounds before any formula reaches production. But the company does not ask practitioners or families to take that process on faith.
Every new batch of Agebox products undergoes independent third-party testing across four risk categories of particular relevance to pediatric nutrition. Several panels in this framework—including growth hormone secretagogue screening—reflect the company’s proactive decision to test beyond standard industry requirements, ensuring that every batch meets the same rigorous benchmarks.
Heavy metals (lead, arsenic, mercury, chromium, cadmium): independently tested by SGS against strict purity limits. All results within compliance benchmarks.
Hormonal adulterants (androgens, progestogens, estrogens, glucocorticoids—35 compounds in total): independently tested by SGS at zero-tolerance thresholds (LOQ 50 μg/kg). None detected.
Growth hormone secretagogues (GHRPs 1–6, MK-677, Ipamorelin, Hexarelin, and seven additional compounds): independently tested by Eurofins at zero-tolerance thresholds (LOQ 2 ng/g). None detected.
Pesticide residues and microbial contaminants: independently tested by SGS. All results within pathogen-free and zero-tolerance benchmarks.
These results, organized by product and test category, are publicly available in the Agebox Safety Hub at agebox.com/pages/safety-hub. The hub is not a curated highlights page—it is a comprehensive, unfiltered display of every test panel conducted. Practitioners are encouraged to review it directly and share it with families who ask about Agebox side effects or ingredient safety.
Manufacturing is conducted at an FDA-registered, cGMP-compliant dietary supplement facility. All products carry the standard FDA dietary supplement disclaimer and are positioned as structure/function support products—not drugs, and not intended to diagnose, treat, cure, or prevent any disease.
The Practitioner Program
Agebox’s global Practitioner Program is open to licensed healthcare professionals—MDs, DOs, NDs, RDs, NPs, PAs—as well as specialized pediatric centers in developmental pediatrics, behavioral intervention, and integrative medicine. Two partnership models are available:
Virtual Dispensary: Families access products through a practitioner’s personalized referral link. Agebox manages inventory, warehousing, and shipping. Practitioners focus on clinical assessment and recommendation; a professional compensation structure is in place to acknowledge the consultative and administrative responsibilities associated with managing personalized nutritional protocols.
Wholesale Program: Designed for clinics with in-office dispensing capability. Tiered pricing is available at scale, with strict MAP (Minimum Advertised Price) policies in place to protect partner margins. Regional exclusivity opportunities exist for established partners.
Both tracks are supported by a Scientific Resource Kit—educational materials, product information sheets, and digital assets—developed to help practitioners communicate the evidence base clearly to families. A Family Trial Program is also available, allowing families to experience products before committing to full-size purchases, reducing friction for practitioners during the recommendation conversation.
Applications are reviewed within 3–5 business days. Practitioners who advance to partnership consultation receive a 15–30 minute overview of the Acesvia™ platform, a discussion of practice fit, and tailored partnership terms. Inquiries can be directed to open@agebox-ops.com.
What This Means for Practice
For practitioners who have been searching for pediatric nutritional support they can recommend with confidence—backed by transparent safety data, a coherent scientific rationale, and operational support that does not burden their team—the Agebox Practitioner Program represents a different kind of partnership. One built not on marketing claims, but on shared standards.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About AGEBOX
AGEBOX Inc. is a U.S.-based biotechnology company that develops evidence-based dietary supplements to support children’s growth, cognition, and metabolic health. The company’s proprietary Acesvia™ Platform uses human cell models to identify and refine GRAS-compliant materials with measurable biological effects. Its formulas, supported by clinical trials, are designed to provide safe, natural, and scientifically grounded support for pediatric needs that are not fully addressed by existing solutions.
